Destination market

GCC Gallbladder Treatment Market Outlook 2026

Gallbladder disease prevalence across the GCC (Saudi Arabia, UAE, Kuwait, Qatar, Bahrain, Oman) drives an estimated USD 480M annual treatment market in 2026, with growing outbound flow to China for elective cholecystectomy at 40–55% of GCC private rates.

← All market reports

Market size (2026)
USD 480 million
CAGR
10.7%
Forecast (2030)
USD 720 million
Geography
Gulf Cooperation Council: Saudi Arabia, UAE, Kuwait, Qatar, Bahrain, Oman
International-patient cost band
$4,500–$7,800 USD

Market size, 20222030

Gulf Cooperation Council: Saudi Arabia, UAE, Kuwait, Qatar, Bahrain, Oman.

YearMarket size (USD)Status
2022USD 320 millionHistorical
2023USD 360 millionHistorical
2024USD 405 millionHistorical
2025USD 440 millionHistorical
2026USD 480 millionLatest actual
2030USD 720 millionForecast

Demand drivers

  • GCC gallstone disease prevalence: ~14–21% in adult Saudi and Emirati cohorts, among the highest globally.
  • Female:male ratio 3:1; peak presentation age 35–55.
  • Obesity prevalence 35%+ in Saudi Arabia and UAE accelerates cholesterol-stone formation.
  • Outbound elective travel for cost: China and Thailand capture ~12% of elective GCC cholecystectomy volume.

Supply-side landscape

  • Local: King Faisal Specialist Hospital, Cleveland Clinic Abu Dhabi, Mediclinic Middle East, Aster.
  • Outbound: laparoscopic cholecystectomy at Class A Chinese international departments is USD 4,500–7,800 vs USD 12,000–22,000 GCC private.
  • Day-case laparoscopic cholecystectomy adoption growing in tier-1 Chinese centres.

Risks & headwinds

  • Acute presentations (cholecystitis, pancreatitis) typically treated locally — outbound is for elective stable disease.
  • GCC insurer coverage of outbound elective surgery varies significantly by emirate.
  • Visa logistics: M-visa processing typically 5–10 business days in UAE.

Frequently asked

How big is the GCC gallbladder treatment market?
USD 480 million in 2026, forecast to USD 720 million by 2030 (10.7% CAGR). Gallstone prevalence in GCC adults is 14–21% — among the highest globally — driven by obesity and dietary factors.
How much does gallbladder surgery cost in China for GCC patients?
USD 4,500–7,800 all-in for laparoscopic cholecystectomy at a Class A international department, vs USD 12,000–22,000 in GCC private settings — a 50–70% saving before travel.
Is cholecystectomy in China safe for international patients?
Yes. Laparoscopic cholecystectomy is a high-volume routine procedure at Class A general surgery departments, with day-case discharge possible in 60%+ of cases. 30-day complication rates are comparable to UK/US private benchmarks.

Sources

  • Saudi Gastroenterology Association prevalence study 2023
  • UAE Ministry of Health & Prevention obesity statistics 2024
  • Partner-network 2026 GCC outbound quote data
  • WHO Regional Office for the Eastern Mediterranean health expenditure 2024

Last reviewed: 2026-05-12.

Going beyond the report

For a written quote from two Class A international departments — covering procedure, hospital match, recovery and visa — start the quote wizard.

Request a quote More market reports